| Home Forums |
|
#1
Tue Apr 27, 2010, 05:34 AM
|
|||
|
|||
|
Treatment options
Hi all,
Here is a discussion about prescribing decisions for high-risk MDS. Emerging therapies are Gemtuzumab (Pfizer’s Mylotarg), Clofarabine (Genzyme’s Clolar/Clofarex/Evoltra) and Vorinostat (Merck & Co.’s Zolinza). http://www.decisionresources.com/Pro...t?r=dbaspd3010 Kind regards Birgitta-A 
|
 |
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cyclosporine before ATG - Newly diagnosed and New Zealand treatment options | Alcof | AA | 8 | Sun Sep 14, 2014 04:11 AM |
| Best treatment options for conversion to AML | Pam Wishart | MDS | 4 | Mon May 16, 2011 02:22 AM |
| Treatment Options | Neel | MDS | 1 | Sat Apr 9, 2011 03:53 PM |
| Interactive Treatment Center Map | Marrowforums | Site Announcements | 0 | Wed Jan 2, 2008 12:22 AM |
